🏥 Health 2d ago

If It's COVID, Paxlovid? Studies Suggest a Rethink These Days

MedPage Today
Medical news for professionals
View Channel →
If It's COVID, Paxlovid? Studies Suggest a Rethink These Days
Source ↗ 👁 0 💬 0
(MedPage Today) -- Oral nirmatrelvir-ritonavir (Paxlovid) failed to spare COVID-19-vaccinated individuals from the worst outcomes if they got sick, though it may have helped speed recovery time and cut viral loads, according to two community-based...

Comments (0)

Sign in to join the discussion

More Like This

Cell Therapy Slows Upper Limb Decline in Duchenne Muscular Dystrophy
MedPageToday.com - medical news for physicians · 17h ago
Potential New Target in Chronic Spontaneous Urticaria
MedPageToday.com - medical news for physicians · 17h ago
FDA Plans Ultra-Fast Review of Three Psychedelics for Depression, PTSD
MedPageToday.com - medical news for physicians · 17h ago
The Health of American Surgeons, We Are Not Okay
Psychology Today: The Latest · 17h ago
Combining Opposites in Creativity: Van Gogh’s Contrasts
Psychology Today: The Latest · 18h ago
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
MedPageToday.com - medical news for physicians · 18h ago